Boomi, the data activation company, today announced it has been recognised as a Leader and positioned highest for Ability to ...

The approval represents a win in what’s been a difficult regulatory environment of late for vaccine makers, and could boost ...

The Health Council of the Netherlands recommends increasing the minimum age for the yearly coronavirus booster from 60 to 70.

Moderna stock jumped late Friday on reports the FDA's top vaccine official, Vinay Prasad, will step down amid mounting ...

Moderna MRNA-1.59%decrease; red down pointing triangle will pay $950 million to settle patent litigation by Arbutus Biopharma and Genevant Sciences GmbH. The vaccine maker said Tuesday that, as part ...

Moderna has faced good and bad times in recent years. Most recently, the FDA refused to review Moderna’s flu candidate -- then reversed course. The company has had its ups -- the approval of its ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech (22UAy.DE), opens new tab sued Moderna (MRNA.O), opens new tab in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot ...

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...

The FDA had previously rejected Moderna's application, refusing even to review it after concluding Moderna hadn't done sufficient safety testing. Now, Moderna is promising to do additional testing to ...

The whiplash over a new potential flu vaccine from Moderna, which went from rejected to approved for review in a matter of days, has illustrated a new reality plaguing the Cambridge biotech company ...

Add Yahoo as a preferred source to see more of our stories on Google. Sarah Silbiger/Getty Images Moderna announced the Food and Drug Administration (FDA) will review its new mRNA flu vaccine, ...